The effects of the COVID-19 outbreak are being felt far and wide across every aspect of our daily lives and businesses. During this time, our number one priority is the health and safety of our employees, their families and their communities. We are following the strict guidelines of our facilities in Boston and Woodland that dramatically reduces the number of employees in our labs and greenhouses, while the remainder of our staff are continuing our efforts from home. We are currently focused on preparing for our 2020 field and greenhouse trials as best we can under these new conditions.
We are closely watching how the situation is evolving on a daily basis and are working with partners to understand how we can adapt and help minimize the impact on the agriculture industry in our new world. We are heartened by the efforts of those working toward a productive and safe 2020 growing season and are proud to be associated with our parent companies Ginkgo Bioworks and Bayer who are doing incredible work to aid in the COVID-19 response.
We are excited to resume business as usual as soon as the time comes. In the meantime, reach out with any questions at email@example.com and we hope you all stay safe and well.
We develop high-performing biologicals that will become a new class of sustainable agriculture solutions.
Every teaspoon of soil is home to billions of microbes
We aim to provide growers with new solutions to feed and nourish the world. By engineering crop-colonizing microbes, we can develop a new class of biologicals that are sustainable and reach unprecedented levels of performance and reliability.
Microbes have evolved alongside plants and contributed to their growth by helping them efficiently access nutrients and protect against pests and diseases. We are plant scientists, microbiologists, synthetic biologists, and data scientists looking to the plant microbiome to drive the development of better and more sustainable solutions for today's farmers.
Our first challenge:
Significantly reducing agriculture's reliance on synthetic nitrogen fertilizer
Our first product will be an engineered microbe that enables cereal crops like corn, wheat, and rice to convert nitrogen from the air into a form they can use to grow. This will significantly reduce the industry's reliance on traditional chemical fertilizer, as well as greenhouse gases produced by agriculture.
Reducing the amount of industrial nitrogen fertilizer would:
We are plant scientists, microbiologists, synthetic biologists, and data scientists.
Our work leverages the synthetic biology leadership of Ginkgo Bioworks with Bayer’s deep knowledge and experience in crop science and ag biologicals.
Agriculture is the original biological technology. The more we can learn to work with the soil microbiome, the more we can discover new ways to add value to farmers and return to agriculture's biological, sustainable roots.
Co-founder of Joyn Bio and CEO of Ginkgo Bioworks
We launched JOYN to develop transformative agricultural products based on the latest synthetic biology technology.
CEO of Joyn Bio
The plant microbiome is one of the next frontiers in sustainable agriculture. And it may enable us to take a major leap in plant physiology: producing nitrogen fertilizer directly in the plant.
Head of Leaps by Bayer